Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005
Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing VEGF expression Source: Eur Respir J 2004; 24: Suppl. 48, 129s Year: 2004
Cysteinyl leukotriene receptor 1 gene variation and risk of asthma Source: Eur Respir J 2009; 33: 42-48 Year: 2009
Leukotriene C4 synthase polymorphism does not associate with clinical response to leukotriene receptor antagonists in persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002
Homozygosity for the FCER2 gene is associated with an increased use of leukotriene receptor antagonists Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017
A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
GB001, a selective prostaglandin D2 receptor 2 antagonist, blocks signaling in the peripheral blood of healthy subjects Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020
Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016
Expression of cysteinyl leukotriene 1 receptor in peripheral blood stem cell-derived human basophils Source: Eur Respir J 2006; 28: Suppl. 50, 856s Year: 2006
The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
Enhanced platelet activating factor receptor (PAFR) expression in smoker airways Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011
Selective versus non-selective endothelin receptor antagonists Source: Annual Congress 2005 - New treatments in pulmonary hypertension Year: 2005
Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
Endothelin receptor antagonists (ERAs) neutralize LPS-induced cytokine release from pulmonary vascular smooth muscle cells (PVSMCs) by down-regulation of CD14 Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013
Promoter polymorphisms of cysteinyl leukotriene type 1 receptor in patients with severe asthma Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007
The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
Inhibition of eosinophil migration by montelukast, a cysteinyl leukotriene receptor antagonist, through down regulation of plasmin activity Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004
A leukotriene antagonist, montelukast, reduces in vitro LTD4 increases in peripheral blood eosinophil progenitor colonies in atopic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004
Expression on peripheral blood (PB) and induced sputum (IS) neutrophils (N) of the IL-8 receptors CXCR1 and CXCR2. Comparison between neutrophilic asthma and COPD Source: Annual Congress 2003 - From gene to breath analysis in airway disorders Year: 2003